Salem Investment Counselors Inc Pfizer Inc Transaction History

Salem Investment Counselors Inc

$2.99 Billion
Q4 2024

A detailed history of Salem Investment Counselors Inc transactions in Pfizer Inc stock. As of the latest transaction made, Salem Investment Counselors Inc holds 126,093 shares of PFE stock, worth $3.39 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

126,093

Previous 130,501 3.38%

Holding current value

$3.39 Million

Previous $3.78 Million 11.41%

% of portfolio

0.11%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$24.8 - $30.19 $109,318 - $133,077	-4,408 Reduced 3.38%	126,093 $3.35 Million
Q3 2024 Oct 15, 2024	SELL	$27.7 - $31.39 $38,253 - $43,349	-1,381 Reduced 1.05%	130,501 $3.78 Million
Q2 2024 Jul 11, 2024	SELL	$25.26 - $29.6 $114,781 - $134,502	-4,544 Reduced 3.33%	131,882 $3.69 Million
Q1 2024 Apr 11, 2024	SELL	$25.89 - $29.73 $628,997 - $722,290	-24,295 Reduced 15.12%	136,426 $3.79 Million
Q4 2023 Jan 16, 2024	SELL	$26.13 - $33.94 $1.02 Million - $1.33 Million	-39,189 Reduced 19.6%	160,721 $4.63 Million
Q3 2023 Oct 04, 2023	SELL	$32.09 - $37.51 $7.74 Million - $9.05 Million	-241,261 Reduced 54.69%	199,910 $6.63 Million
Q2 2023 Jul 19, 2023	SELL	$36.12 - $41.79 $403,713 - $467,086	-11,177 Reduced 2.47%	441,171 $16.2 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $82,128 - $106,918	2,085 Added 0.46%	452,348 $18.5 Million
Q4 2022 Feb 15, 2023	SELL	$41.75 - $54.5 $386,605 - $504,670	-9,260 Reduced 2.02%	450,263 $23.1 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $1.37 Million - $1.67 Million	31,294 Added 7.31%	459,523 $20.1 Million
Q2 2022 Aug 17, 2022	SELL	$46.53 - $55.17 $36,339 - $43,087	-781 Reduced 0.18%	428,229 $22.5 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $711,183 - $881,246	15,545 Added 3.76%	429,010 $22.2 Million
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $191,766 - $284,261	4,641 Added 1.14%	413,465 $24.4 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $544,476 - $699,426	13,872 Added 3.51%	408,824 $17.6 Million
Q2 2021 Aug 17, 2021	BUY	$35.91 - $40.68 $371,201 - $420,509	10,337 Added 2.69%	394,952 $15.5 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $1.23 Million - $1.39 Million	36,707 Added 10.55%	384,615 $13.9 Million
Q4 2020 Feb 17, 2021	BUY	$33.47 - $42.56 $1.11 Million - $1.41 Million	33,043 Added 10.49%	347,908 $12.8 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $1.09 Million - $1.28 Million	34,293 Added 12.22%	314,865 $11.6 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $1.05 Million - $1.28 Million	34,948 Added 14.23%	280,572 $9.18 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $405,233 - $578,991	-14,992 Reduced 5.75%	245,624 $8.02 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $50,828 - $57,683	1,544 Added 0.6%	260,616 $10.2 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $12,833 - $16,641	-395 Reduced 0.15%	259,072 $9.31 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $40,604 - $45,588	-1,098 Reduced 0.42%	259,467 $11.2 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $190,162 - $208,925	5,071 Added 1.98%	260,565 $11.5 Million
Q4 2018 Feb 15, 2019	SELL	$38.47 - $43.86 $195,081 - $222,414	-5,071 Reduced 1.95%	255,494 $11.2 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $674,371 - $817,970	-19,564 Reduced 6.98%	260,565 $11.5 Million
Q2 2018 Aug 15, 2018	SELL	$32.98 - $35.16 $272,183 - $290,175	-8,253 Reduced 2.86%	280,129 $10.2 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $300,751 - $348,913	-9,425 Reduced 3.16%	288,382 $10.3 Million
Q4 2017 Feb 16, 2018	BUY	$33.26 - $35.29 $70,843 - $75,167	2,130 Added 0.72%	297,807 $10.8 Million
Q3 2017 Nov 16, 2017	BUY	$31.0 - $34.15 $9.17 Million - $10.1 Million	295,677	295,677 $10.6 Million

Others Institutions Holding PFE

# of Institutions

3,224

Shares Held

3.61B

Call Options Held

77.1M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $151B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.

Account

Salem Investment Counselors Inc Pfizer Inc Transaction History